EMPI INC

EMPI Inc. operates at the intersection of the Electromedical & Electrotherapeutic Apparatus industry, developing and selling non-invasive pain management and physical therapy systems geared toward hospitals, clinics, and rehabilitation professionals that seek safe adjuncts to rehabilitation and chronic pain care. Its core offerings revolve around programmable electrical stimulation and related accessories, with a focus on delivering clinical-grade options that comply with the stringent product safety and medical device regulations that define SIC 3841 and adjacent classifications, and the company keeps a sharp eye on FDA guidance as well as reimbursement pressure that can affect uptake. While EMPI’s relatively modest profile and limited public record—highlighting a Form 8-K filed in September 1999—mean investors must weigh limited disclosure and the long gap between filings as operational risks, the firm’s entrenched customer base and specialized expertise in electrotherapy machinery help sustain relevance. Mentioning CIK 317032 keeps filings traceable; view live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025